Cytokine priming shifts mitochondrial architecture and extracellular vesicle cargo of feline placental mesenchymal stromal cells toward an immunosuppressive phenotype.
Аннотация
OBJECTIVE
To characterize effects of inflammatory cytokine priming on viability, mitochondrial morphology, and extracellular vesicle (EV) cargo in feline placenta-derived mesenchymal stromal cells (MSCs).
METHODS
Feline placenta-derived MSCs from 7 healthy cats were cultured under control, serum-deprived, or cytokine-stimulated (tumor necrosis factor-α, interferon-γ, IL-1, IL-6) conditions in vitro. Viability/apoptosis were assessed by flow cytometry and mitochondrial morphology by confocal microscopy with MicroP/MATLAB; EVs were characterized by surface markers, RNA sequencing, and microRNA (miR) profiling.
RESULTS
Viability exceeded 96% across all conditions, with no significant intergroup differences. Kiel 67 proliferation marker and metabolic activity were significantly reduced under serum-free and cytokine-stimulated conditions versus controls (both P < .001). Cytokine priming increased branching and simple tubular mitochondria, whereas serum deprivation increased fragmented forms. Extracellular vesicle transcriptomics identified 329 differentially expressed genes, including upregulated immunosuppressive receptors C-C motif chemokine receptor 8 and poliovirus receptor-related immunoglobulin domain-containing protein and downregulated proinflammatory histone transcripts. microRNA (miR) profiling revealed 23 differentially expressed miRs, with enrichment of anti-inflammatory miR-204, let-7g, and miR-181b-2 and depletion of proinflammatory miR-34a and miR-320a.
CONCLUSIONS
Cytokine priming induces mitochondrial elongation and shifts EV cargo toward an immunosuppressive phenotype without compromising viability, supporting inflammatory priming as a strategy to optimize MSC-based therapies for T-cell-mediated inflammatory diseases.
CLINICAL RELEVANCE: Inflammatory priming prior to MSC administration may enhance therapeutic efficacy in cats, supporting investigation of cytokine licensing as a translatable approach to improving MSC therapy outcomes in veterinary medicine.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.